Detalhe da pesquisa
1.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36692409
2.
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
Mycoses
; 66(1): 35-46, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36064299
3.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36651870